{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:31:48Z","timestamp":1790937108433,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1082619"],"award-info":[{"award-number":["APP1082619"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Intracellular pathogens mobilize host signaling pathways of their host cell to promote their own survival. Evidence is emerging that signal transduction elements are activated in a-nucleated erythrocytes in response to infection with malaria parasites, but the extent of this phenomenon remains unknown. Here, we fill this knowledge gap through a comprehensive and dynamic assessment of host erythrocyte signaling during infection with\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    . We used arrays of 878 antibodies directed against human signaling proteins to interrogate the activation status of host erythrocyte phospho-signaling pathways at three blood stages of parasite asexual development. This analysis reveals a dynamic modulation of\u00a0many host signalling proteins across parasite development. Here we focus on the hepatocyte growth factor receptor (c-MET) and the MAP kinase pathway component B-Raf, providing a proof of concept that human signaling kinases identified as activated by malaria infection represent attractive targets for antimalarial intervention.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-17829-7","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T06:05:13Z","timestamp":1597125913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Analysis of erythrocyte signalling pathways during Plasmodium falciparum infection identifies targets for host-directed antimalarial intervention"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8415-7539","authenticated-orcid":false,"given":"Jack D.","family":"Adderley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1951-9940","authenticated-orcid":false,"given":"Simona","family":"John von Freyend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan J.","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"Anar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Metcalf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Semblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1716-168X","authenticated-orcid":false,"given":"Oliver","family":"Billker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5073-1405","authenticated-orcid":false,"given":"Danny W.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3188-094X","authenticated-orcid":false,"given":"Christian","family":"Doerig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"17829_CR1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(04)15836-4","volume":"363","author":"B Singh","year":"2004","unstructured":"Singh, B. et al. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet363, 1017\u20131024 (2004).","journal-title":"Lancet"},{"key":"17829_CR2","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.1016\/S2214-109X(17)30333-9","volume":"5","author":"P Brasil","year":"2017","unstructured":"Brasil, P. et al. Outbreak of human malaria caused by Plasmodium simium in the Atlantic Forest in Rio de Janeiro: a molecular epidemiological investigation. Lancet Glob. Health5, e1038\u2013e1046 (2017).","journal-title":"Lancet Glob. Health"},{"key":"17829_CR3","unstructured":"WHO. World Malaria Report (WHO, 2017)."},{"key":"17829_CR4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","volume":"16","author":"K Haldar","year":"2018","unstructured":"Haldar, K., Bhattacharjee, S. & Safeukui, I. Drug resistance in Plasmodium. Nat. Rev. Microbiol.16, 156\u2013170 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"17829_CR5","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0804-2","volume":"17","author":"KS Bhullar","year":"2018","unstructured":"Bhullar, K. S. et al. Kinase-targeted cancer therapies: progress, challenges and future directions. Mol. Cancer17, 48 (2018).","journal-title":"Mol. Cancer"},{"key":"17829_CR6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.phrs.2019.03.006","volume":"144","author":"R Roskoski Jr.","year":"2019","unstructured":"Roskoski, R. Jr. Properties of FDA-approved small molecule protein kinase inhibitors. Pharm. Res.144, 19\u201350 (2019).","journal-title":"Pharm. Res."},{"key":"17829_CR7","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-5-79","volume":"5","author":"P Ward","year":"2004","unstructured":"Ward, P., Equinet, L., Packer, J. & Doerig, C. Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote. BMC Genomics5, 79 (2004).","journal-title":"BMC Genomics"},{"key":"17829_CR8","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.4155\/fmc.12.183","volume":"4","author":"IS Lucet","year":"2013","unstructured":"Lucet, I. S., Tobin, A., Drewry, D., Wilks, A. F. & Doerig, C. Plasmodium kinases as targets for new-generation antimalarials. Future Med Chem.4, 2295\u20132310 (2013).","journal-title":"Future Med Chem."},{"key":"17829_CR9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/acsinfecdis.7b00268","volume":"4","author":"S Schor","year":"2018","unstructured":"Schor, S. & Einav, S. Combating intracellular pathogens with repurposed host-targeted drugs. ACS Infect. Dis.4, 88\u201392 (2018).","journal-title":"ACS Infect. Dis."},{"key":"17829_CR10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1084\/jem.2128insight5","volume":"212","author":"KW Deitsch","year":"2015","unstructured":"Deitsch, K. W. Self-targeting blocks malaria parasite invasion. J. Exp. Med.212, 1143 (2015).","journal-title":"J. Exp. Med."},{"key":"17829_CR11","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1084\/jem.20150032","volume":"212","author":"ZA Zenonos","year":"2015","unstructured":"Zenonos, Z. A. et al. Basigin is a druggable target for host-oriented antimalarial interventions. J. Exp. Med.212, 1145\u20131151 (2015).","journal-title":"J. Exp. Med."},{"key":"17829_CR12","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.1371\/journal.pmed.0030528","volume":"3","author":"SC Murphy","year":"2006","unstructured":"Murphy, S. C. et al. Erythrocyte G protein as a novel target for malarial chemotherapy. PLoS Med.3, e528 (2006).","journal-title":"PLoS Med."},{"key":"17829_CR13","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1126\/science.1089324","volume":"301","author":"T Harrison","year":"2003","unstructured":"Harrison, T. et al. Erythrocyte G protein-coupled receptor signaling in malarial infection. Science301, 1734\u20131736 (2003).","journal-title":"Science"},{"key":"17829_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/JRLCR.S99725","volume":"9","author":"FB Ntumngia","year":"2016","unstructured":"Ntumngia, F. B., Thomson-Luque, R., Pires, C. V. & Adams, J. H. The role of the human Duffy antigen receptor for chemokines in malaria susceptibility: current opinions and future treatment prospects. J. Receptor Ligand Channel Res.9, 1\u201311 (2016).","journal-title":"J. Receptor Ligand Channel Res."},{"key":"17829_CR15","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1462-5822.2011.01582.x","volume":"13","author":"A Sicard","year":"2011","unstructured":"Sicard, A. et al. Activation of a PAK-MEK signalling pathway in malaria parasite-infected erythrocytes. Cell Microbiol.13, 836\u2013845 (2011).","journal-title":"Cell Microbiol."},{"key":"17829_CR16","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood.V89.5.1770","volume":"89","author":"BS Hall","year":"1997","unstructured":"Hall, B. S., Daramola, O. O., Barden, G. & Targett, G. A. Modulation of protein kinase C activity in Plasmodium falciparum-infected erythrocytes. Blood89, 1770\u20131778 (1997).","journal-title":"Blood"},{"key":"17829_CR17","doi-asserted-by":"crossref","first-page":"e92411","DOI":"10.1371\/journal.pone.0092411","volume":"9","author":"M Brizuela","year":"2014","unstructured":"Brizuela, M. et al. Treatment of erythrocytes with the 2-cys peroxiredoxin inhibitor, Conoidin A, prevents the growth of Plasmodium falciparum and enhances parasite sensitivity to chloroquine. PLoS ONE9, e92411 (2014).","journal-title":"PLoS ONE"},{"key":"17829_CR18","doi-asserted-by":"crossref","first-page":"13323","DOI":"10.1073\/pnas.0905387106","volume":"106","author":"S Koncarevic","year":"2009","unstructured":"Koncarevic, S. et al. The malarial parasite Plasmodium falciparum imports the human protein peroxiredoxin 2 for peroxide detoxification. Proc. Natl Acad. Sci. USA106, 13323\u201313328 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"17829_CR19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.molbiopara.2016.05.006","volume":"208","author":"TG Carvalho","year":"2016","unstructured":"Carvalho, T. G. et al. The ins and outs of phosphosignalling in Plasmodium: parasite regulation and host cell manipulation. Mol. Biochem Parasitol.208, 2\u201315 (2016).","journal-title":"Mol. Biochem Parasitol."},{"key":"17829_CR20","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.cellsig.2007.01.018","volume":"19","author":"ER Park","year":"2007","unstructured":"Park, E. R., Eblen, S. T. & Catling, A. D. MEK1 activation by PAK: a novel mechanism. Cell Signal.19, 1488\u20131496 (2007).","journal-title":"Cell Signal."},{"key":"17829_CR21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrc3645","volume":"14","author":"M Radu","year":"2014","unstructured":"Radu, M., Semenova, G., Kosoff, R. & Chernoff, J. PAK signalling during the development and progression of cancer. Nat. Rev. Cancer14, 13\u201325 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"17829_CR22","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-1-6","volume":"1","author":"LM Elandalloussi","year":"2002","unstructured":"Elandalloussi, L. M. & Smith, P. J. Preparation of pure and intact Plasmodium falciparum plasma membrane vesicles and partial characterisation of the plasma membrane ATPase. Malar. J.1, 6 (2002).","journal-title":"Malar. J."},{"key":"17829_CR23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.chom.2012.12.001","volume":"13","author":"MG Millholland","year":"2013","unstructured":"Millholland, M. G. et al. A host GPCR signaling network required for the cytolysis of infected cells facilitates release of apicomplexan parasites. Cell Host Microbe13, 15\u201328 (2013).","journal-title":"Cell Host Microbe"},{"key":"17829_CR24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bcmd.2016.02.001","volume":"58","author":"G Bouyer","year":"2016","unstructured":"Bouyer, G. et al. Plasmodium falciparum infection induces dynamic changes in the erythrocyte phospho-proteome. Blood Cells Mol. Dis.58, 35\u201344 (2016).","journal-title":"Blood Cells Mol. Dis."},{"key":"17829_CR25","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1110\/ps.072874607","volume":"16","author":"A Welman","year":"2007","unstructured":"Welman, A., Griffiths, J. R., Whetton, A. D. & Dive, C. Protein kinase C delta is phosphorylated on five novel Ser\/Thr sites following inducible overexpression in human colorectal cancer cells. Protein Sci.16, 2711\u20132715 (2007).","journal-title":"Protein Sci."},{"key":"17829_CR26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/bj3610255","volume":"361","author":"Y Liu","year":"2002","unstructured":"Liu, Y., Graham, C., Li, A., Fisher, R. J. & Shaw, S. Phosphorylation of the protein kinase C-theta activation loop and hydrophobic motif regulates its kinase activity, but only activation loop phosphorylation is critical to in vivo nuclear-factor-kappaB induction. Biochem J.361, 255\u2013265 (2002).","journal-title":"Biochem J."},{"key":"17829_CR27","first-page":"197","volume":"3","author":"X Wang","year":"2012","unstructured":"Wang, X., Chuang, H. C., Li, J. P. & Tan, T. H. Regulation of PKC-theta function by phosphorylation in T cell receptor signaling. Front Immunol.3, 197 (2012).","journal-title":"Front Immunol."},{"key":"17829_CR28","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1093\/emboj\/19.20.5429","volume":"19","author":"BH Zhang","year":"2000","unstructured":"Zhang, B. H. & Guan, K. L. Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO J.19, 5429\u20135439 (2000).","journal-title":"EMBO J."},{"key":"17829_CR29","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1093\/emboj\/20.14.3716","volume":"20","author":"H Chong","year":"2001","unstructured":"Chong, H., Lee, J. & Guan, K. L. Positive and negative regulation of Raf kinase activity and function by phosphorylation. EMBO J.20, 3716\u20133727 (2001).","journal-title":"EMBO J."},{"key":"17829_CR30","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.bbamcr.2007.05.001","volume":"1773","author":"DT Leicht","year":"2007","unstructured":"Leicht, D. T. et al. Raf kinases: function, regulation and role in human cancer. Biochim. Biophys. Acta1773, 1196\u20131212 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"17829_CR31","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1365-2958.2007.05859.x","volume":"65","author":"D Dorin-Semblat","year":"2007","unstructured":"Dorin-Semblat, D. et al. Functional characterization of both MAP kinases of the human malaria parasite Plasmodium falciparum by reverse genetics. Mol. Microbiol.65, 1170\u20131180 (2007).","journal-title":"Mol. Microbiol."},{"key":"17829_CR32","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1007\/s00018-016-2297-8","volume":"73","author":"D Lake","year":"2016","unstructured":"Lake, D., Correa, S. A. & Muller, J. Negative feedback regulation of the ERK1\/2 MAPK pathway. Cell Mol. Life Sci.73, 4397\u20134413 (2016).","journal-title":"Cell Mol. Life Sci."},{"key":"17829_CR33","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1038\/sj.onc.1209640","volume":"25","author":"T Brummer","year":"2006","unstructured":"Brummer, T. et al. Functional analysis of the regulatory requirements of B-Raf and the B-Raf(V600E) oncoprotein. Oncogene25, 6262\u20136276 (2006).","journal-title":"Oncogene"},{"key":"17829_CR34","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1093\/emboj\/18.8.2137","volume":"18","author":"CS Mason","year":"1999","unstructured":"Mason, C. S. et al. Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. EMBO J.18, 2137\u20132148 (1999).","journal-title":"EMBO J."},{"key":"17829_CR35","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1093\/emboj\/cdf588","volume":"21","author":"T Brummer","year":"2002","unstructured":"Brummer, T., Shaw, P. E., Reth, M. & Misawa, Y. Inducible gene deletion reveals different roles for B-Raf and Raf-1 in B-cell antigen receptor signalling. EMBO J.21, 5611\u20135622 (2002).","journal-title":"EMBO J."},{"key":"17829_CR36","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1128\/MCB.24.6.2308-2317.2004","volume":"24","author":"ST Eblen","year":"2004","unstructured":"Eblen, S. T. et al. Mitogen-activated protein kinase feedback phosphorylation regulates MEK1 complex formation and activation during cellular adhesion. Mol. Cell Biol.24, 2308\u20132317 (2004).","journal-title":"Mol. Cell Biol."},{"key":"17829_CR37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbrc.2011.11.145","volume":"417","author":"R Roskoski Jr.","year":"2012","unstructured":"Roskoski, R. Jr. MEK1\/2 dual-specificity protein kinases: structure and regulation. Biochem. Biophys. Res. Commun.417, 5\u201310 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"17829_CR38","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/bfgp\/els022","volume":"11","author":"JL Bromberg-White","year":"2012","unstructured":"Bromberg-White, J. L., Andersen, N. J. & Duesbery, N. S. MEK genomics in development and disease. Brief. Funct. Genomics11, 300\u2013310 (2012).","journal-title":"Brief. Funct. Genomics"},{"key":"17829_CR39","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/j.1460-2075.1991.tb08021.x","volume":"10","author":"DM Payne","year":"1991","unstructured":"Payne, D. M. et al. Identification of the regulatory phosphorylation sites in pp42\/mitogen-activated protein kinase (MAP kinase). EMBO J.10, 885\u2013892 (1991).","journal-title":"EMBO J."},{"key":"17829_CR40","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1158\/0008-5472.CAN-14-2073","volume":"74","author":"EM Goetz","year":"2014","unstructured":"Goetz, E. M., Ghandi, M., Treacy, D. J., Wagle, N. & Garraway, L. A. ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors. Cancer Res.74, 7079\u20137089 (2014).","journal-title":"Cancer Res."},{"key":"17829_CR41","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1091\/mbc.E15-07-0527","volume":"27","author":"S Lai","year":"2016","unstructured":"Lai, S. & Pelech, S. Regulatory roles of conserved phosphorylation sites in the activation T-loop of the MAP kinase ERK1. Mol. Biol. Cell27, 1040\u20131050 (2016).","journal-title":"Mol. Biol. Cell"},{"key":"17829_CR42","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/1758834011422556","volume":"3","author":"SL Organ","year":"2011","unstructured":"Organ, S. L. & Tsao, M. S. An overview of the c-MET signaling pathway. Ther. Adv. Med. Oncol.3, S7\u2013S19 (2011).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"17829_CR43","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1083\/jcb.129.5.1177","volume":"129","author":"R Zarnegar","year":"1995","unstructured":"Zarnegar, R. & Michalopoulos, G. K. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J. Cell Biol.129, 1177\u20131180 (1995).","journal-title":"J. Cell Biol."},{"key":"17829_CR44","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood.V97.4.1063","volume":"97","author":"L Teofili","year":"2001","unstructured":"Teofili, L. et al. Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease. Blood97, 1063\u20131069 (2001).","journal-title":"Blood"},{"key":"17829_CR45","first-page":"2019","volume":"9","author":"GA Rodrigues","year":"1994","unstructured":"Rodrigues, G. A. & Park, M. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase. Oncogene9, 2019\u20132027 (1994).","journal-title":"Oncogene"},{"key":"17829_CR46","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1073\/pnas.0712176105","volume":"105","author":"M Emaduddin","year":"2008","unstructured":"Emaduddin, M., Bicknell, D. C., Bodmer, W. F. & Feller, S. M. Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cells. Proc. Natl Acad. Sci. USA105, 2358\u20132362 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"17829_CR47","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S1097-2765(01)00378-1","volume":"8","author":"P Peschard","year":"2001","unstructured":"Peschard, P. et al. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol. Cell8, 995\u20131004 (2001).","journal-title":"Mol. Cell"},{"key":"17829_CR48","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1128\/MCB.17.2.799","volume":"17","author":"M Jeffers","year":"1997","unstructured":"Jeffers, M., Taylor, G. A., Weidner, K. M., Omura, S. & Vande Woude, G. F. Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway. Mol. Cell Biol.17, 799\u2013808 (1997).","journal-title":"Mol. Cell Biol."},{"key":"17829_CR49","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1258\/ebm.2011.010394","volume":"236","author":"S Neelam","year":"2011","unstructured":"Neelam, S., Kakhniashvili, D. G., Wilkens, S., Levene, S. D. & Goodman, S. R. Functional 20S proteasomes in mature human red blood cells. Exp. Biol. Med. (Maywood)236, 580\u2013591 (2011).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"17829_CR50","doi-asserted-by":"crossref","first-page":"11100","DOI":"10.1158\/0008-5472.CAN-06-2554","volume":"66","author":"AJ King","year":"2006","unstructured":"King, A. J. et al. Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885. Cancer Res.66, 11100\u201311105 (2006).","journal-title":"Cancer Res."},{"key":"17829_CR51","first-page":"3904","volume":"15","author":"J Zhi","year":"2018","unstructured":"Zhi, J. et al. Effects of PHA-665752 and vemurafenib combination treatment on in vitro and murine xenograft growth of human colorectal cancer cells with BRAF(V600E) mutations. Oncol. Lett.15, 3904\u20133910 (2018).","journal-title":"Oncol. Lett."},{"key":"17829_CR52","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15158","volume":"8","author":"G Haqshenas","year":"2017","unstructured":"Haqshenas, G. et al. Signalome-wide assessment of host cell response to hepatitis C virus. Nat. Commun.8, 15158 (2017).","journal-title":"Nat. Commun."},{"key":"17829_CR53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.celrep.2018.12.068","volume":"26","author":"G Haqshenas","year":"2019","unstructured":"Haqshenas, G. et al. A role for the insulin receptor in the suppression of dengue virus and Zika virus in Wolbachia-infected mosquito cells. Cell Rep.26, 529\u2013535 e523 (2019).","journal-title":"Cell Rep."},{"key":"17829_CR54","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1046\/j.1432-1327.2001.02403.x","volume":"268","author":"C Syin","year":"2001","unstructured":"Syin, C. et al. The H89 cAMP-dependent protein kinase inhibitor blocks Plasmodium falciparum development in infected erythrocytes. Eur. J. Biochem.268, 4842\u20134849 (2001).","journal-title":"Eur. J. Biochem."},{"key":"17829_CR55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/5584_2018_273","volume":"1111","author":"BE Turk","year":"2019","unstructured":"Turk, B. E. Exceptionally selective substrate targeting by the metalloprotease anthrax lethal factor. Adv. Exp. Med. Biol.1111, 189\u2013203 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"17829_CR56","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/sj.onc.1208401","volume":"24","author":"S Cornelis","year":"2005","unstructured":"Cornelis, S. et al. Apoptosis of hematopoietic cells induced by growth factor withdrawal is associated with caspase-9 mediated cleavage of Raf-1. Oncogene24, 1552\u20131562 (2005).","journal-title":"Oncogene"},{"key":"17829_CR57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41388-018-0465-z","volume":"38","author":"JAM Merilahti","year":"2019","unstructured":"Merilahti, J. A. M. & Elenius, K. Gamma-secretase-dependent signaling of receptor tyrosine kinases. Oncogene38, 151\u2013163 (2019).","journal-title":"Oncogene"},{"key":"17829_CR58","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5483\/BMBRep.2019.52.4.024","volume":"52","author":"M Fernandes","year":"2019","unstructured":"Fernandes, M., Duplaquet, L. & Tulasne, D. Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase. BMB Rep.52, 239\u2013249 (2019).","journal-title":"BMB Rep."},{"key":"17829_CR59","doi-asserted-by":"crossref","first-page":"e0139591","DOI":"10.1371\/journal.pone.0139591","volume":"10","author":"D Dorin-Semblat","year":"2015","unstructured":"Dorin-Semblat, D. et al. Malaria parasite-infected erythrocytes secrete PfCK1, the Plasmodium homologue of the pleiotropic protein kinase casein kinase 1. PLoS ONE10, e0139591 (2015).","journal-title":"PLoS ONE"},{"key":"17829_CR60","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2958.2006.05521.x","volume":"63","author":"MC Nunes","year":"2007","unstructured":"Nunes, M. C., Goldring, J. P., Doerig, C. & Scherf, A. A novel protein kinase family in Plasmodium falciparum is differentially transcribed and secreted to various cellular compartments of the host cell. Mol. Microbiol.63, 391\u2013403 (2007).","journal-title":"Mol. Microbiol."},{"key":"17829_CR61","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager, W. & Jensen, J. B. Human malaria parasites in continuous culture. Science193, 673\u2013675 (1976).","journal-title":"Science"},{"key":"17829_CR62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28457-z","volume":"8","author":"O Lyth","year":"2018","unstructured":"Lyth, O. et al. Cellular dissection of malaria parasite invasion of human erythrocytes using viable Plasmodium knowlesi merozoites. Sci. Rep.8, 10165 (2018).","journal-title":"Sci. Rep."},{"key":"17829_CR63","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1126\/science.3299700","volume":"236","author":"D Walliker","year":"1987","unstructured":"Walliker, D. et al. Genetic analysis of the human malaria parasite Plasmodium falciparum. Science236, 1661\u20131666 (1987).","journal-title":"Science"},{"key":"17829_CR64","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11187","volume":"7","author":"S Dankwa","year":"2016","unstructured":"Dankwa, S. et al. Ancient human sialic acid variant restricts an emerging zoonotic malaria parasite. Nat. Commun.7, 11187 (2016).","journal-title":"Nat. Commun."},{"key":"17829_CR65","doi-asserted-by":"crossref","unstructured":"Hill, D. L., Eriksson, E. M. & Schofield, L. High yield purification of Plasmodium falciparum merozoites for use in opsonizing antibody assays. J. Vis. Exp. 51590 (2014).","DOI":"10.3791\/51590"},{"key":"17829_CR66","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-7-45","volume":"7","author":"C Ribaut","year":"2008","unstructured":"Ribaut, C. et al. Concentration and purification by magnetic separation of the erythrocytic stages of all human Plasmodium species. Malar. J.7, 45 (2008).","journal-title":"Malar. J."},{"key":"17829_CR67","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/AAC.01607-06","volume":"51","author":"JD Johnson","year":"2007","unstructured":"Johnson, J. D. et al. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob. Agents Chemother.51, 1926\u20131933 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"17829_CR68","doi-asserted-by":"crossref","unstructured":"Wilson, D. W., Crabb, B. S. & Beeson, J. G. Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays. Malar. J.9, 152 (2010).","DOI":"10.1186\/1475-2875-9-152"},{"key":"17829_CR69","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ejmech.2017.10.010","volume":"148","author":"N Nguyen","year":"2018","unstructured":"Nguyen, N. et al. Broad activity of diphenyleneiodonium analogues against Mycobacterium tuberculosis, malaria parasites and bacterial pathogens. Eur. J. Med. Chem.148, 507\u2013518 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"17829_CR70","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1128\/AAC.01881-12","volume":"57","author":"DW Wilson","year":"2013","unstructured":"Wilson, D. W., Langer, C., Goodman, C. D., McFadden, G. I. & Beeson, J. G. Defining the timing of action of antimalarial drugs against Plasmodium falciparum. Antimicrob. Agents Chemother.57, 1455\u20131467 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"17829_CR71","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/978-1-62703-026-7_35","volume":"923","author":"JW Lin","year":"2013","unstructured":"Lin, J. W. et al. Screening inhibitors of P. berghei blood stages using bioluminescent reporter parasites. Methods Mol. Biol.923, 507\u2013522 (2013).","journal-title":"Methods Mol. Biol."},{"key":"17829_CR72","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molbiopara.2004.04.007","volume":"137","author":"B Franke-Fayard","year":"2004","unstructured":"Franke-Fayard, B. et al. A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol. Biochem. Parasitol.137, 23\u201333 (2004).","journal-title":"Mol. Biochem. Parasitol."},{"key":"17829_CR73","doi-asserted-by":"crossref","first-page":"9632","DOI":"10.1128\/MCB.25.21.9632-9645.2005","volume":"25","author":"JV Abella","year":"2005","unstructured":"Abella, J. V. et al. Met\/Hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation. Mol. Cell Biol.25, 9632\u20139645 (2005).","journal-title":"Mol. Cell Biol."},{"key":"17829_CR74","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrm3012","volume":"11","author":"L Trusolino","year":"2010","unstructured":"Trusolino, L., Bertotti, A. & Comoglio, P. M. MET signalling: principles and functions in development, organ regeneration and cancer. Nat. Rev. Mol. Cell Biol.11, 834\u2013848 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"17829_CR75","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nm947","volume":"9","author":"M Carrolo","year":"2003","unstructured":"Carrolo, M. et al. Hepatocyte growth factor and its receptor are required for malaria infection. Nat. Med.9, 1363\u20131369 (2003).","journal-title":"Nat. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17829-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17829-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17829-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T19:11:28Z","timestamp":1670267488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17829-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["17829"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-17829-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.09.143206","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,11]]},"assertion":[{"value":"3 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4015"}}